Good Intentions

<p>With communities of color disproportionately impacted by COVID-19, drugmakers and public health officials are placing an unprecedented emphasis on diversity in vaccine clinical trials.</p><p><br></p><p>Guests:</p><p><a href="https://www.mcrmed.com/about/leadership-team/" rel="noopener noreferrer" target="_blank">Beau Garland</a>, Vice President of Recruitment, Meridian Clinical Research</p><p><a href="https://www.massgeneral.org/research/division-clinical-research/centers-units-and-faculty/care/jonathan-jackson" rel="noopener noreferrer" target="_blank">Jonathan Jackson, PhD</a>, Director, CARE Research Center, Massachusetts General Hospital.</p><p><br></p><p>For complete complete transcript of this conversation: <a href="https://tradeoffs.org/2020/10/27/good-intentions/" rel="noopener noreferrer" target="_blank">https://tradeoffs.org/2020/10/27/good-intentions/</a></p><p><br></p><p>To stay on top of all our coverage of the coronavirus and our conversations with people who are being forced to make difficult decisions in the midst of it all, visit <a href="http://bit.ly/coronavirustradeoffs" rel="noopener noreferrer" target="_blank">http://bit.ly/coronavirustradeoffs</a>.</p><p><br></p><p>Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: <a href="https://create.acast.com/episodes/723a3a91-aa98-4a64-91a9-ec3049cc20d7/bit.ly/tradeoffsnewsletter" rel="noopener noreferrer" target="_blank">bit.ly/tradeoffsnewsletter</a></p><p>Follow us on Twitter:&nbsp;<a href="https://twitter.com/tradeoffspod" rel="noopener noreferrer" target="_blank">https://twitter.com/tradeoffspod</a></p> &#10;&nbsp;<br /><hr><p style='color: grey; font - size: 0.75em; '>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.</p>